Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.
about
Contribution of Vesicular Glutamate Transporters to Stress Response and Related Psychopathologies: Studies in VGluT3 Knockout Mice.Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.Cortical thickness reduction in combat exposed U.S. veterans with and without PTSD.Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic.Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.A Network-Based Neurobiological Model of PTSD: Evidence From Structural and Functional Neuroimaging Studies.Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety.Single-Prolonged Stress: A Review of Two Decades of Progress in a Rodent Model of Post-traumatic Stress Disorder.Fearful dogs have increased plasma glutamine and γ-glutamyl glutamineCombat Exposure Severity is Associated with Reduced Cortical Thickness in Combat Veterans: A Preliminary ReportPosttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat VeteransThe Association of PTSD Symptom Severity with Localized Hippocampus and Amygdala AbnormalitiesTraumatic Stress Produces Distinct Activations of GABAergic and Glutamatergic Neurons in Amygdala
P2860
Q38641772-88A15E37-945F-4A0F-B3AF-56D178A573F7Q38820487-25B683A2-09C6-4F86-8014-5472D4925DE5Q38921265-DC07CE35-E14A-4C79-B416-CF1620F56CACQ45326808-1CDA2EFB-BAFF-4989-B365-AC29427CD161Q47636416-6E62AE0F-72C8-4F2B-85BD-E11DC269E619Q47823561-51C0EE14-A879-47B8-97F2-460006F8AF6FQ47941947-2A53D2D2-8417-4389-BB81-7D947063A7CCQ53689134-741BB3DE-59D8-44AD-8CDE-3ECC780CAE6BQ55109281-B1DCA97F-77B8-476D-95E5-0CF45867E400Q58107332-5879BF4B-EBAA-49E6-846F-E685BF37C411Q58213312-BC77E245-8AC8-4521-B809-CE5FDE7A1F66Q58213313-39FF9F94-4A0C-4DF6-99B4-2D329D6A95A7Q58213876-3411298D-E6B0-47FC-8458-5CF15A365F19Q58728640-69E9C86F-DD16-44BA-BE0A-A09117A83C96
P2860
Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Glutamate dysregulation and gl ...... : Evidence from human studies.
@en
type
label
Glutamate dysregulation and gl ...... : Evidence from human studies.
@en
prefLabel
Glutamate dysregulation and gl ...... : Evidence from human studies.
@en
P2093
P2860
P50
P1433
P1476
Glutamate dysregulation and gl ...... : Evidence from human studies.
@en
P2093
John H Krystal
Markus A Boesl
Prerana Purohit
P2860
P304
P356
10.1016/J.NEULET.2016.11.064
P407
P577
2016-12-01T00:00:00Z